Trending Health Vynamic

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes.Podcast Tags: healthcare, life sciences, patient engagement, patient centricity, patient outcomes, social media, metrics, innovationDisclaimer: Nico is sharing his own opinions, which might not necessarily reflect Roche’s perspectiveCheck out Nico’s profile LinkedIn profile here: https://www.linkedin.com/in/nicorenner/ (https://www.linkedin.com/in/nicorenner/) Source Links: * Harnessing the Power of Social Media in Pharmaceutical Marketing (%5C)  * Pharma and Healthcare Social Media Marketing Market (%5C) * The Relationship Between the Pharmaceutical Industry and Social Media (%5C) * Intelligent Post-launch Patient Support (%5C) * Patient Education on Social Media is not the future… (%5C) Panel – Jack Young, Nico Renner and Jen BurkeResearch & Production – Jack Young, Nico Renner and Jen BurkeRecording & Editing –Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine Source Links: * Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference (%5C) * ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation (%5C) * ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? (%5C) * ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth (%5C) * At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer (%5C) * What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck (%5C) * Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up (%5C) * Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up (%5C) * ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine (%5C) * Moderna And Merck Advance Cancer Treatment With Promising Vaccine (%5C) * NHS patients in England to be offered trials for world-first cancer vaccine (%5C) * Thousands of cancer patients to trial personalised vaccines (%5C) Panel – Jack Young, Jen Burke, Ollie May Research & Production – Jack Young, Karan Pandya Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC.

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools. Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation  Source Links: * The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog (%5C) * Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com) (%5C) * A Practical Guide to Enabling AI within your Organization. (youtube.com) (%5C)   * Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com) (%5C) Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon Research & Production – Everly Petruzzelli, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com) (%5C), Lantern’s LinkedIn Page, (%5C) Build and Modernize AI Apps – Microsoft Azure Marketplace (%5C) If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting (%5C) For additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC. 

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare. Podcast Tags: healthcare, healthcare news, health policy, drug shortages, Medicare, hospitals, providers, FDA, telehealth, inflation reduction act, IRA, ride share, Lyft, Uber  Source Links:* Senators float Medicare program that would offer incentive payments to combat drug shortages (%5C)   * Second House panel advances two-year telehealth extension (%5C) * Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits (%5C) * CMS proposes new mandatory organ transplant model for end-stage renal disease (%5C) Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC.

During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact.To receive a copy of Vynamic’s ”Operating with Impact: Topical Transformation Dilemmas and Decisions” presentation, please email gemmapfister@vynamic.com (gemmapfister@vynamic.com)For more information about Vynamic’s work in Medical Affairs, please visit https://vynamic.com/what-we-do/health-industry/life-sciences/medical-affairs/ (https://vynamic.com/what-we-do/health-industry/life-sciences/medical-affairs/) Podcast Tags: healthcare, healthcare news, life sciences, medical affairs, MASS East, Fierce, MSL Panel – Gemma Pfister, Jen Burke, Tamaron Bertelli  Research & Production – Danielle Lewis, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week Source Links: * ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web (%5C) * Huge volume of NHS patient and staff data released by hacker (%5C) * NHS cyber attack: Why stolen medical information is so much more valuable than financial data (%5C) * Cyber attacks are one of the biggest threats facing healthcare systems (%5C) * Government Launches NHS Cyber Security Strategy (%5C) * US tech group Palantir wins lucrative NHS data contract (%5C) * Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract (%5C) * European Commission lays down path to future-proof EU biotechnology (%5C) * Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies (%5C) * Roche agrees $7.1bn deal for Telavant to boost drug pipeline  (%5C) * Europe’s biotech innovation in the balance (%5C) * Commission takes action to boost biotechnology and biomanufacturing in the EU (%5C) * Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis (%5C) * EU launches landmark €6.5M study on use of psychedelics to treat mental disorders (%5C) * Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy (%5C) * Psychedelic drug research held back by UK rules and attitudes, say scientists (%5C) * King’s College Psychoactive Trials Group (%5C) Panel – Jack Young, Jen Burke, Ollie May Research & Production – Karan Pandya, Jack Young Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com (%5C) or share a voicemail at 1-888-VYNAMIC.